{ "cik": 318306, "cik_padded": "0000318306", "entityName": "ABEONA THERAPEUTICS INC.", "fiscal_years": [ { "accn": "0001493152-26-010413", "filed": "2026-03-17", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 7975000.0, "cash": 78437000.0, "eps_diluted": 1.01, "free_cash_flow": -84301000.0, "net_income": 71183000.0, "operating_cash_flow": -76326000.0, "operating_income": -89448000.0, "stockholders_equity": 159216000.0, "total_assets": 219570000.0, "total_liabilities": 60354000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3790699427193247, "roa_avg2y": 0.4333807203022213, "roa_period_end": 0.3241927403561506, "roe_avg2y": 0.7004580633416483, "roe_period_end": 0.44708446387297757 } }, { "accn": "0001493152-26-010413", "filed": "2026-03-17", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2446000.0, "cash": 23357000.0, "eps_diluted": -1.55, "free_cash_flow": -58461000.0, "net_income": -63734000.0, "operating_cash_flow": -56015000.0, "operating_income": -64211000.0, "stockholders_equity": 44031000.0, "total_assets": 108931000.0, "total_liabilities": 64900000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.4739615271059026, "roa_avg2y": -0.737094712981328, "roa_period_end": -0.5850859718537422, "roe_avg2y": -2.1657237032128718, "roe_period_end": -1.4474801844155254 } }, { "accn": "0001493152-26-010413", "filed": "2026-03-17", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 331000.0, "cash": 14473000.0, "eps_diluted": -2.53, "free_cash_flow": -37340000.0, "net_income": -54188000.0, "operating_cash_flow": -37009000.0, "operating_income": -47135000.0, "stockholders_equity": 14826000.0, "total_assets": 64002000.0, "total_liabilities": 49176000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 3.3168757588021043, "roa_avg2y": -0.8452611218568665, "roa_period_end": -0.8466610418424423, "roe_avg2y": -2.6060066847813017, "roe_period_end": -3.654930527451774 } }, { "accn": "0001493152-25-010978", "filed": "2025-03-20", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 130000.0, "cash": 14217000.0, "eps_diluted": -5.53, "free_cash_flow": -43613000.0, "net_income": -39696000.0, "operating_cash_flow": -43483000.0, "operating_income": -50915000.0, "stockholders_equity": 26761000.0, "total_assets": 64214000.0, "total_liabilities": 37453000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.3995366391390456, "roa_avg2y": -0.5521001390820585, "roa_period_end": -0.6181829507584016, "roe_avg2y": -1.148461571843944, "roe_period_end": -1.4833526400358732 } }, { "accn": "0001493152-24-010190", "filed": "2024-03-18", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 4151000.0, "cash": 32938000.0, "free_cash_flow": -69816000.0, "net_income": -84936000.0, "operating_cash_flow": -65665000.0, "operating_income": -89836000.0, "stockholders_equity": 42368000.0, "total_assets": 79586000.0, "total_liabilities": 37218000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.878445996978852, "roa_avg2y": -0.7360648918469218, "roa_period_end": -1.0672228783956976, "roe_avg2y": -1.1721858417460789, "roe_period_end": -2.0047205438066467 } }, { "accn": "0001493152-23-009381", "filed": "2023-03-29", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1336000.0, "cash": 12596000.0, "free_cash_flow": -36355000.0, "net_income": -84234000.0, "operating_cash_flow": -35019000.0, "operating_income": -81420000.0, "stockholders_equity": 102551000.0, "total_assets": 151198000.0, "total_liabilities": 48647000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4743688506206668, "roa_avg2y": -0.44975172192856, "roa_period_end": -0.5571105437902618, "roe_avg2y": -0.5995707894839865, "roe_period_end": -0.821386432116703 } }, { "accn": "0001493152-22-008259", "filed": "2022-03-31", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6309000.0, "cash": 129258000.0, "free_cash_flow": -69129000.0, "net_income": -76282000.0, "operating_cash_flow": -62820000.0, "operating_income": -77090000.0, "stockholders_equity": 178430000.0, "total_assets": 223382000.0, "total_liabilities": 44952000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2519307291374769, "roa_avg2y": -0.3835376752534686, "roa_period_end": -0.3414867804926091, "roe_avg2y": -0.4882438595087607, "roe_period_end": -0.4275177940929216 } }, { "accn": "0001493152-21-006705", "filed": "2021-03-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 9243000.0, "cash": 18750000.0, "free_cash_flow": -48354000.0, "net_income": -56671000.0, "operating_cash_flow": -39111000.0, "operating_income": -58166000.0, "stockholders_equity": 134045000.0, "total_assets": 174399000.0, "total_liabilities": 40354000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.30104815547017794, "roa_avg2y": -0.32093214219982164, "roa_period_end": -0.32495025774230357, "roe_avg2y": -0.37266022890548195, "roe_period_end": -0.4227759334551829 } }, { "accn": "0001493152-20-004015", "filed": "2020-03-16", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 860000.0, "cash": 137750000.0, "free_cash_flow": -23515000.0, "net_income": -27319000.0, "operating_cash_flow": -22655000.0, "operating_income": -27836000.0, "stockholders_equity": 170098000.0, "total_assets": 178766000.0, "total_liabilities": 8668000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.05095885901068796, "roa_avg2y": -0.18852130948437673, "roa_period_end": -0.1528198874506338, "roe_avg2y": -0.20296735464122795, "roe_period_end": -0.16060741454925986 } }, { "accn": "0001493152-20-004015", "filed": "2020-03-16", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 519000.0, "cash": 69142000.0, "free_cash_flow": -13533000.0, "net_income": -21873000.0, "operating_cash_flow": -13014000.0, "operating_income": -23881000.0, "stockholders_equity": 99098000.0, "total_assets": 111058000.0, "total_liabilities": 11960000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.12068861127368867, "roa_period_end": -0.19695114264618488, "roe_period_end": -0.22072090254091908 } }, { "accn": "0001144204-15-020126", "filed": "2015-03-31", "fiscal_year": 2014, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -15.26 }, "period_end": "2014-12-31", "ratios": {} }, { "accn": "0001144204-15-020126", "filed": "2015-03-31", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": 3.04 }, "period_end": "2013-12-31", "ratios": {} }, { "accn": "0000318306-14-000006", "filed": "2014-03-26", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "eps_diluted": "USD/shares" }, "fundamentals": { "eps_diluted": -0.52 }, "period_end": "2012-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001493152-26-010413", "filed": "2026-03-17", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000318306.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000318306.json" }, "ticker": "ABEO" }